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Hydrochiorothiazide inhibits bone resorption in men despite experi-
mentally elevated serum 1,25-dihydroxyvitamin D concentrations. We
evaluated the effects of hydrochlorothiazide administration in relation
to Ca balance, the PTH and vitamin D endocrine systems, acid-base
balance, and bone. We studied six healthy men fed constant diets
providing only 5.1 0.7 SD mmoles CaJday. Three of the men were
also given calcitriol, 0.5 sg 6-hrly throughout their studies. All subjects
were observed during 18 control days and then during 18 days of
hydrochlorothiazide (HTZ) administration, 25 mg 12-hrly. Observations
during control days 11 through 16 were compared to those during days
7 through 18 of HTZ administration, inclusively. Directional changes
during HTZ did not differ among subjects not given or given calcitriol.
For all six subjects, control net intestinal Ca absorption, serum 1,25-
(OH)2-D concentrations, serum iPTH concentrations, and daily urine
cAMP excretion averaged 0.5 2.2 mmoles/day, 162 51 pt, 4.3
2.2 d Eq/ml and 4.2 0.9 moles/day, respectively; none changed
during HTZ. As expected, HTZ administration was accompanied by a
fall in urinary Ca excretion, averaging — 1.4 0.8 mmoles/day; P <
0.01. HTZ administration was also accompanied by less negative Ca
balances, averaging + 1.6 1.0 mmoles/day; P < 0.025, and by a fall
in daily unnary hydroxyproline excretion averaging — 0.13 0.09
mmoles/day; P < 0.025. We interpret these data to indicate that HTZ
administration is accompanied by an inhibition of bone resorption. HTZ
administration also raised serum HCO3 concentrations by + 2.7 0.5
mEqlliter; P < 0.001 and blood pH by + 0.05 0.02 units; P < 0.005.
Since HTZ administration did not change either serum iFFH or 1,25-
(OH)2-D concentrations nor urinary cAMP excretion, inhibition of bone
resorption may be mediated by either relative alkalosis, a reduced
skeletal sensitivity to PTH or 1 ,25-(OH)2-D, or, possibly, by a direct
effect of HTZ on bone.
L'hydrochlorothiazide inhibe Ia resorption osseuse chez l'homme en
dépit de concentrations expérimentalement élevées de Ia 1,25-dihydroxy-
vitamine D serique. Nous avons étudié les effets de l'administration de
l'hydrochlorothiazide sur Ia balance calcique, Ia PTH, la vitamine D, la
balance acido-basique et l'os. Nous avons étudié 6 sujets sains recevant
un régime constant amenant seulement 5,1 0,7 SD mmoles de calcium
par jour. Trois de ces hommes recevalent Cgalement du calcitriol, 0,5 g
toutes les 6 heures tout au long de l'étude. Tous les sujets ont eté
étudiés pendant une pCriode contrôle de 18 jours et ensuite pendant 18
jours d'administration de l'hydrochlorothiazide (HTZ), 25 mg toutes les
12 heures. On a compare les résultats obtenus entre les jours 11 et 16
inclus de la période contrôle et ceux obtenus 7 et 18 inclus de
l'administration de HTZ. Les modifications directionnelles pendant
l'HTZ n'ont pas etC diffCrentes selon que les sujets ont recu ou non du
calcitriol. Pour les 6 sujets, l'absorption intestinale nette contrOle du
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calcium, les concentrations de 1 ,25-(OH)2-D sCrique, les concentra-
tions de iPTH sCrique et l'excrCtion quotidienne urinaire de cAMP
Ctaient de 0,5 2,2 mmoles/jour, 162 51 pmoles, 4,3 2,2 ilEq/ml
et 4,2 0,9 smoles/jour, respectivement; aucune n'a etC modifiée par
l'HTZ. Comme prCvu, l'administration d'HTZ s'est accompagnCe
d'une chute de l'excrCtion urinaire du calcium, de 1,4 0,8
mmoles/jour ; p < 0,01. L'administration d'HTZ a aussi etC ac-
compagnCe par des balances du calcium moms negatives, de + 1,6
1,0 mmoles/jour ; p < 0,025, et par une chute de l'excrCtion urinalre
quotidienne d'hydroxyproline de — 0,13 0,09 mmoles/jour; p <0,025.
Nous interpretons ces rCsultats comme indiquant que l'administration
d'HTZ est accompagnee par une inhibition de la resorption osseuse.
L'administration d'HTZ a aussi augmentC les concentrations sCriques
de HCO3 de + 2,7 0,5 mEq/1 ; p <0,001 et le pH sanguin de + 0,05
0,02 unites, p < 0,005. Dans Ia mesure ou l'administration d'HTZ n'a
pas modiflC l'iPTH sCrique ou la 1,25-(OH)2-D, ni l'excrCtion urinaire
de cAMP, l'inhibition de la resorption osseuse pourrait étre provoquée
soit par une alcalose relative, soit par une diminution de Ia sensibilité du
squelette a la PTH ou a la 1 ,25-(OH)2-D ou peut-Ctre par un effet direct
de I'HTZ sur l'os.
Chronic administration of the thiazide diuretics has recently
been observed to be accompanied by increased bone density in
humans [11. These drugs are well known for their ability to
reduce urinary calcium excretion [21 by augmenting distal renal
tubular calcium reabsorption [3]. However, net intestinal cal-
cium absorption in humans is apparently not altered by the
acute administration of thiazides [4, 5]. The combination of
reduced urinary calcium excretion and unaltered net intestinal
calcium absorption would necessarily result in the retention of
calcium in the body, presumably in bone. The present studies
were undertaken to re-evaluate the effects of thiazide diuretics
on the components of calcium balance and bone resorption in
relation to serum 1 ,25-(OH)2-D concentrations as well as serum
parathyroid hormone levels and acid-base homeostasis in
healthy men.
Methods
We studied six healthy men, aged 22 to 29 years, in the
Medical College of Wisconsin Clinical Research Center with
their consent using a protocol approved by the Medical College
of Wisconsin Human Research Review Committee. Each sub-
ject ate a constant whole-food diet throughout his study that
provided for the group an average of only 5.1 0.7 SD mmoles
Calday. Two menus of comparable composition were alternated
951
952 Lemann et a!
daily and duplicate diets were analyzed. The diets also con-
tained 58.0 4.2 mmoles PO4Iday, 18.8 1.0 mmoles Mg/day,
178 5 mmoles Na/day, 85 4 mmoles K/day, 156 9mmoles
CL/day, and an estimated 3250 330 kcallday (47 4
kcallkglday). The diets did not contain gelatin. Three of the six
subjects were also given calcitriol, 0.5 g, 6-hrly (at 0600, 1200,
1800 and 2400 hours) beginning 7 days before they started the
constant diet while they ate a low-calcium diet at home and
continuing throughout their studies. We chose to use the
low-calcium diet because we wished to observe the subjects
when net bone resorption must have been occurring. Healthy
men cannot achieve calcium balance on such low calcium
intakes [6] and Ca balance becomes even more negative during
1 ,25-(OH)2-D administration because of the effect of this hor-
mone to stimulate net bone resorption [6]. In addition, a low Ca
intake would provide a setting in which a small effect of the
thiazides to alter fecal Ca excretion and net intestinal Ca
absorption might become detectible. Each subject was adapted
to his constant diet for 4 days and then observed during two
6-day control periods and two additional days to permit passage
of the carmine used to demarcate the end of the second control
stool period. The subjects were then given hydrochlorothiazide
(HTZ), starting at a dose of 12.5 mg, l2-hrly (at 0600 and 1800
hours) for 3 days and then 25 mg, l2-hrly while observations
were continued during three 6-day experimental periods. Three
subjects complained of weakness while receiving HTZ and,
because of hypokalemia (serum K 3.3—3.5 mEq/liter), these
three subjects were given supplementary KC1 28, 31, and 35
mEq/day. Although carmine was used to mark the 6-day stool
periods, feces were actually pooled every 2 to 4 days to permit
more frequent estimates of fecal mineral excretion and thus net
intestinal mineral absorption. Twenty-four-hr urines were col-
lected and, in addition, 6-day urine pools were prepared for
some analyses. Fasting morning blood specimens were col-
lected on five control and six experimental days and additional
bloods were collected during the day at times corresponding to
2 and 4 hrs after the last meal or the last dose of calcitriol on
four occasions during control and four occasions during HTZ
administration.
The methods employed for the analyses of diets, urine, feces,
and serum have been described [6, 7]. Parathyroid hormone
was measured using antibody detecting both intact PTH and
carboxy-terminal fragments kindly provided by Dr. Eduardo
Slatopoisky, Washington University School of Medicine, St.
Louis, Missouri, USA. Serum 1 ,25-(OH)2-D concentrations
were measured using the calf thymus receptor for competitive
binding assay after extraction of the serum samples with
acetonitrile and purification using sequential C18 and silica
"Sep-paks" [8]. Twenty-three serum specimens with 1,25-
(OH)2-D concentrations ranging from 35 to 190 pM using HPLC
purification and the chick duodenal receptor [7] exhibited
similar values when also analyzed by the calf-thymus method; r
= 0.75.
Results are presented as individual data, individual means
SD, or the average of these individual means for the group SD.
The means of the individual changes from control for the group
during HTZ were evaluated by the paired t test. Fecal Ca
excretion during control and during HTZ were also compared
by two-way analysis of variance [9]. Because of the delay in
adaptation to a low-calcium diet [6] and to the steady-state
25 31 37
Fig. 1. Mean daily body weights (•) and mean daily sodium (S) and
potassium balances (•) for the six subjects during control and during
HTZ administration. Urinary Na and K excretion rates were measured
in 6-day urine pools during control and during days 7 through 18 of HTZ
and daily during days 1 through 6 of HTZ.
effects of HTZ, average balances during the second control
period were compared to those during the second and third
HTZ periods. Since the directional changes from control during
HTZ were similar regardless of the administration of calcitriol,
data for all six subjects were pooled to simplify their
presentation.
Results
The results are summarized in Figures 1 through 4 and Tables
1 through 4.
Control conditions
As shown in Figure 1, average body wts for the group
increased slightly during control, but were nearly stable during
the second control period (Table 2). Sodium and potassium
balances were positive but stable (Fig. 1 and Table 2). The other
measured constituents of the blood, feces, and urine were also
stable during the second control period (Figs. 2 and 3, Tables 1
through 4). We could not detect a diurnal variation in serum
l,25-(OH)2-D concentrations [10, 11]. For the three subjects
who ate the low-calcium diet alone, control serum 1 ,25-(OH)2-D
concentrations, without regard to time of day, averaged 121
26, 109 19, and 124 20 pM. During the second control
period, these subjects exhibited rates of net intestinal calcium
absorption that averaged — 1.5 0.3 mmoles/day (Fig. 2), a
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value significantly less than zero but within the range of — 2 to
+ 1 mmoles/day expected for subjects adapted to a low-calcium
diet [6]. Calcium balances for these three subjects averaged —
3.0 1.5 mmoles/day. For the three subjects who also received
calcitriol, control serum 1,25-(OH)2-D levels averaged 181
47, 226 27, and 211 26 pM. During the second control
period, these three subjects exhibited, as expected, positive
rates of net intestinal calcium absorption that averaged 2.6
0.6 mmoles/day (Fig. 3), a significantly positive value (P <
0.025). Nevertheless, because of a greater increase in urinary
calcium excretion, their calcium balances averaged —4.4 2.5
mmoles/day, a value that was slightly more negative than that
observed for the subjects who ate the low-calcium diet alone.
[6].
Effects of hydroch/orothiazide
As shown in Figure 1, the administration of HTZ was
accompanied, as expected, by transiently more negative Na and
K balances and a loss in body wt. The maximum loss in body wt
occurred during the first two days of HTZ administration and
averaged — 1.27 kg for all six subjects. During these two days,
Na balance became more negative by an average total of 203
mEq when expressed as the cumulative change from control.
Potassium losses continued after the sodium diuresis. Cumula-
tive potassium balances during the first six days of HTZ
averaged for the group 145 mEq, corrected for average daily
control balances. During the second and third 6-day periods of
HTZ administration, body wt rose slightly as in the second
control period and Na and K balances were similar to control.
As shown in Figures 2 and 3, HTZ administration promptly
reduced urinary calcium excretion in all subjects regardless of
calcitriol administration, an effect that was sustained during the
second and third HTZ periods, at the end of which body wt had
been restored to levels indistinguishable from control (Table 2).
HTZ had no detectable effect on net intestinal calcium absorp-
tion (Figs. 2 and 3, Table 2). Thus, as a consequence of the
persistent decrease in urinary calcium excretion, average cal-
cium balances became significantly less negative during the
second and third HTZ periods by + 1.6 1.0 mmoles/day; P <
0.025 (Table 2). Hydrochlorothiazide had no effect on fecal or
urinary excretion rates or the balances of the other minerals
during the second and third HTZ periods (Table 2). However,
average daily fecal wet weight fell significantly (Table 2).
As shown in Table 3, the administration of HTZ was accom-
panied by a significant fall in daily urinary hydroxyproline
excretion. Daily urinary creatinine excretion did not change,
indicating that urine collections were appropriate and complete.
However, because of the slight but significant rise in serum
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Fig. 2. Net intestinal Ca absorption, urina,y Ca excretion, and Ca
balances before and during hydrochlorothiazide administration for the
three subjects who ate the low-Ca diet alone. Each symbol identifies a
subject.
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Fig. 3. Net intestinal Ca absorption, urinary Ca excretion, and Ca
balances before and during hydrochiorothiazide administration for the
three subjects who ate the low-Ca diet and also were given calcitriol 0.5
j.g 6-hrly continuously. Each symbol identifies a subject.
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10 — Discussion
Since the administration of HTZ was accompanied by less
negative calcium balances together with a decrease in daily
urinary hydroxyproline excretion, it would appear that HTZ
inhibits bone resorption. The validity of the indirect estimates
of net bone resorption in humans upon which this interpretation
is based require consideration.
Calcium balances became significantly less negative during
HTZ due solely to the fall in urinary calcium excretion, an effect
that was sustained (Figs. 2 and 3) despite the slight rise in serum
total calcium concentrations (Table 1) and the apparent resto-
A ration of extracellular fluid volume during days 7 through 19 ofHTZ administration as judged by the return of body wt to
control levels at the end of the studies and unchanged Na
balances (Fig. I and Table 2). The possibility remains that we
could have failed to detect a quantitatively equivalent decline in
net intestinal calcium absorption because of the variability of
this measurement (Figs. 2 and 3). When net intestinal Ca
_____
absorption for all six subjects during control and during HTZ
were compared using two-way analysis of variance, we found
that net intestinal absorption of Ca would have had to have
decreased by an average of — 1.2 mmoles/day to detect a
statistically significant (P <0.05) compensatory fall in intestinal
Ca absorption. Such a small change could have escaped detec-
tion. That HTZ has no effect to inhibit basal or I ,25-(OH)2-D-
stimulated net intestinal calcium transport in these men is
consistent with previous studies in both humans [4, 5] and in
rats [14].
It also might be argued that the mean retention of 1.6 mmoles
Caiday relative to control for the 12 days of the second and third
HTZ periods (Table 2), cumulatively totaling 19.2 mmoles,
might have been retained at sites other than bone. This possi-
bility also seems unlikely. The rise in total serum calcium of
0.05 mmoles/liter, if distributed in the extracellular fluid (ne-
glecting protein binding of calcium in plasma) could account for
less than 5% (less than 1 mmoles) of the retained calcium. If
calcium were retained within cells it would have to be contin-
uously sequestered in a normally calcium-rich compartment
such as mitochondria, but there is no evidence for such a
potentially pathological process. Since long-term thiazide ad-
ministration has not been reported to be accompanied by
ectopic calcification, pathological sites of calcium deposition
are also unlikely.
Daily excretion of total urinary hydroxyproline reflects both
collagen synthesis and degradation in bone as well as in other
tissues such as the skin and also has been adopted as a rough
index of both bone turnover and bone resorption [15]. We have
previously observed that daily urinary hydroxyproline excre-
tion rates are inversely correlated to calcium balances in
healthy subjects studied at varying levels of dietary calcium
intake and, in addition, when net bone resorption was stimu-
lated by the administration of calcitriol to subjects fed a
low-calcium diet [6, 7]. These considerations thus also support
the interpretation that the decline in daily urinary hydroxypro-
line excretion during HTZ administration accompanying the
less negative calcium balances reflected inhibition of bone
resorption.
Although the present studies do not provide precise insights
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FIg. 4. Individual mean serum iPTH concentrations as a function of
individual mean serum 1,25-(OH)2-D concentrations during control
(open symbols) and during hydrochiorothiazide administration (solid
symbols)for the subjects who ate the low-Ca diet alone (circles) and the
subjects also given calcitriol (triangles). y = 10.9—0.0423x, r = — 0.85;
P < 0.001.
creatinine (Table 1), estimated endogenous creatinine clear-
ances fell slightly but significantly (Table 3). Neither serum
phosphate concentrations (Table 1), nor the components of
phosphate balance (Table 2) changed.
Hydrochlorothiazide had no effect on serum 1 ,25-(OH)2-D
concentrations (Table 1). Hydrochlorothiazide also had no
effect on serum PTH concentrations (Table 1) nor on daily
urinary cAMP excretion (Table 3). However, as shown in
Figure 4, serum PTH concentrations were inversely correlated
to serum 1 ,25-(OH)2-D concentrations [7, 12, 13] regardless of
the administration of HTZ.
Table 4 presents the effects of HTZ on serum bicarbonate
concentrations, pCO2, and blood pH as well as the components
of acid balance during the second control and third HTZ
periods. Hydrochlorothiazide administration, as expected, was
accompanied by the development of a significant rise in serum
bicarbonate without a change in pCO2 and thus a rise in blood
pH. The components of fixed acid production were unaffected
by HTZ administration. The urine was slightly, but not signif-
icantly, more alkaline during HTZ administration and this
change was accompanied by a slight, but significant, rise in
urinary bicarbonate excretion. Offsetting this rise in urinary
bicarbonate excretion was a slight, but significant, rise in
urinary ammonium excretion. As a consequence of these op-
posite directional changes, net acid excretion did not change.
Thus, since neither acid production nor acid excretion changed,
acid balance, which was not different from zero during the
control period, was unchanged during HTZ administration.
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Table 1. Mean blood composition in six men during control and during hydrochiorothiazide administration
Control HTZ A P
Serum total Ca, mmoles/liter
P04, mmoles/liter
Mg, mmoles/liter
iPTH, 1EqIml
1,25-(OH)2-D, pmoles/liter
25-OH-D, nmoles/liter
Creatinine, rsmoles/liter
Na, mmoles/liter
K, mmoles/liter
Cl, mmoles/liter
Total protein, gIdi
2.36 0.07 2.42 0.08
1.48 0.07 1.48 0.11
0.89 0.07 0.90 0.10
4.4 1.8 3.6 1.9
162 51 157 45
60 17 60 17
99 8 105 9
142 1 142 1
4.0 0.2 3.5 0.2
106 1 100 1
6.5 0.4 6.4 0.4
0.06 0.02
0 0.05
0.01 0.06
—0.8 0.9
—5 8
0 6
6 4
0 1
—0.5 0.2
—6 I
—0.1 0.4
<0.005
NS
NS
NS
NS
NS
<0.01
NS
<0.001
<0.001
NS
Table 2. Body weight, fecal weight, and mineral balances
Control HTZ
(Period II) (Periods II and III) A P
Initial body wt, kg
Final body wt, kg
A wt, kg/day
Fecal wt, glday
Diet Ca, mmoles/day
Fecal Ca, mmoles/day
Net intestinal Ca absorption, mmoles/day
Urine Ca, mmoles/day
Ca balance, mmoles/day
Diet P04, mmoles/day
Fecal P04, mmoles/day
Net intestinal P04 absorption, mmoles/day
Urine P04, mmoles/day
P04 balance, mmoles/day
Diet Mg, mmoles/day
Fecal Mg, mmoles/day
Net intestinal Mg absorption, ,nmoleslday
Urine Mg, mmoles/day
Mg balance, mmoles/day
Diet Na, mmoles/day
Fecal Na, mmoles/day
Net intestinal Na absorption, mmoles/day
Urine Na, mmoles/day
Na balance, mmoles/day
Diet K, mmoles/day
Fecal K, mmoles/day
Net intestinal K absorption, mmoles/day
Urine K, mmoles/day
K balance, mmoles/day
Diet Cl, mmoles/day
Fecal Cl, mmoles/day
Net intestinal Cl absorption, mmoles/day
Urine Cl, mmoles/day
Cl balance, mmoles/day
70.53 13.41 69.93 13.20
70.75 13.15 70.49 13.29
+0.04 0.07 +0.05 0.03
126 25 99 29
5.1 0.7 5.1 0.7
4.6 2.4 4.4 2.6
+0.5 2.2 +0.7 2.3
4.3 3.3 2.9 2.7
—3.8 2.0 —2.2 1.3
58.0 4.2 58 4.2
16.7 2.5 15.0 4.7
41.3 3.9 43.0 7.1
32.7 5.4 35.0 3.8
+8.6 4.1 +8.0 7.6
18.8 1.0 18.8 1.0
13.2 2.4 11.6 2.9
5.6 2.7 7.2 2.5
4.4 0.8 5.0 0.6
1.2 2.4 +2.2 2.4
178 5 178 5
3 1 1 1
175 6 177 5
149 12 145 12
+26 7 +32 9
85 4 100 18
15 2 13 3
70 4 87 19
56 5 73 11
+14 S +14 11
156 9 172 22
1 1 1 1
155 8 171 22
132 10 138 14
+23 16 +33 21
+0.01 0.08
—27 24
0
—0.2 1.1
+0.2 1.1
—1.4 0.8
—1.6 1.0
0
—1.7 4.5
+1.7 4.5
2.3 2.6
—0.6 4.9
0
—1.6 3.0
+1.6 3.0
+0.6 0.6
+1.0 3.2
0
—2 2
+2 2
—4 9
+6 10
+15 17
—2 4
+17 19
+17 17
0 9
+16 17
0 1
+16 17
+6 15
+10 10
NS
<0.05
NS
NS
NS
<0.01
< 0.025
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
into the mechanism or mechanisms by which HTZ administra-
tion apparently inhibits bone resorption, several possibilities
can be considered.
First, if the rise in serum total calcium concentration can be
taken as an index of ionized calcium (and not a rise in the
concentration of protein-bound calcium due either to persistent
diuretic-induced volume depletion or alkalosis), such a rise
might theoretically directly inhibit bone resorption. However,
elevation of medium Ca concentrations did not inhibit either
basal or PTH-stimulated bone resorption in cultured fetal bone
[16].
Second, if a rise in ionized calcium occurred, such an
increase could have indirectly inhibited bone resorption by a
suppression of P1'H secretion. Some previous studies have
suggested that PTH is necessary for the anti-calciuric effects of
the thiazide diuretics [17, 18], but not for the anticalciuric
effects of chlorthalidone [19]. PTH was clearly present among
our subjects, but lower among those given calcitriol (Fig. 4).
These variations in basal serum PTH levels did not alter the
response to HTZ. Moreover, we could not detect changes in
either serum PTH concentrations, daily urinary cAMP excre-
tion rates, serum phosphate concentrations, or daily urinary
phosphate excretion during HTZ administration. Thus it ap-
pears unlikely that the apparent decline in bone resorption
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Table 3. Daily urine volume, creatinine excretion, creatinine clearance, hydroxyproline, cAMP, and oxalate excretion during control and
during hydrochlorothiazide administration
Control HTZ P
Volume, mi/day 2480 570 2660 600 + 180 300 NS
Creatinine, mmoles/day 16.7 1,5 16,9 1.6 +0.2 0.6 NS
Creatinine clearance, liters/day 166 19 161 19 —5 4 < 0.05
Hydroxyproline, mmoies/day 0.39 0.04 0.26 0.08 —0.13 0.09 <0.025
cAMP, moies/day 4.2 0.9 4.5 1.2 +0.3 0.8 NS
Oxalate, mmoles/day 0.46 0.04 0.46 0.04 0.00 0.12 NS
Table 4. Blood pH, serum HCO3, and the components of acid balance during control and during hydrochlorothiazide administration
Control HTZ P
Blood pH 7.36 0.03k 7.41 0.03 +0.05 0.02 <0.005
H, pEq/liter 43.1 2.8 39.1 2.2 —4.0 1.9 <0.005
pCO2, mm Hg 47 5 47 5 0 2 NS
HCO3, mEqiliter 26.0 1.9 28.7 1.6 +2.7 0.5 <0.001
Diet unmeasured anion,b mEq/day 50 16 50 16 0 NS
Fecal unmeasured anion, mEq/day 23 4 19 5 —4 5 NS
Urine SO4, mEqiday 37 4 41 4 +4 5 NS
Urine organic anion, SEq/day 48 10 49 10 + 1 3 NS
Net fixed acid production, mEq/day 58 24 59 23 + 1 10 NS
Urine pH 5.94 0.41 6.11 0.36 +0.17 0.23 NS
Urine NH4, mEqiday 43 4 49 5 +6 3 <0.01
Urine titratable acid, mEq/day 23 7 22 6 —1 4 NS
Urine HCO3, mEq/day 3 3 6 3 +3 2 <0.025
Renal net acid excretion,c mEq/day 63 7 65 6 +2 5 NS
Acid balance, mEq/day —5 24 —6 20 +1 10 NS
a Standard deviation.
b Unmeasured anion in diet and in feces calculated as ( Na + K + Ca + Mg, mEq/day) — ( Cl mEq/day + 1.8 P mmoles/day).
Renal net acid excretion = NH4 + titratable acid — HCO3.
during HTZ could have been mediated by suppression of PTH
secretion.
Third, elevated serum 1 ,25-(OH)2-D levels stimulate bone
resorption when dietary calcium intake is low [161. Since serum
1 ,25-(OH)2-D levels did not fall during HTZ neither interference
with renal synthesis of the hormone in the three subjects not
given calcitriol nor accelerated catabolism of the 1 ,25-(OH)2-D
in any of the subjects could have occurred. Thus, a fall in serum
1 ,25-(OH)2-D levels could not have accounted for the apparent
inhibition of bone resorption accompanying HTZ
administration.
Fourth, relative alkalosis may have played a role. We have
reviewed 39 previous balance studies that we have carried out
among healthy volunteers eating a variety of diets providing
normal quantities of calcium while the subjects ate the diet
alone or were also given ammonium chloride [20—23]. In those
studies (Fig. 5), we have observed that serum bicarbonate
concentrations were inversely correlated to daily net external
acid balance: serum bicarbonate, mEq/liter = 24.5 — 0.087 acid
balance, mEq/day; r = — 0.56. Calcium balances were also
inversely correlated to acid balances: calcium balance,
mmoles/day = — 0.23 — 0.18 acid balance, mEq/day; r = —
0.79. Thus, calcium balances were directly correlated to serum
bicarbonate concentrations: calcium balance, mmoles/day = —
23.4 + 0.93 serum bicarbonate, mEq/liter; r = 0.64. If the
changes in serum bicarbonate concentrations participate in
mediating the changes in calcium balance, then the slope of the
latter equation would predict that a rise in serum bicarbonate
concentration of 2.7 mEqlliter (the mean change during HTZ in
the present studies, Table 4) should be accompanied by more
positive calcium balances averaging + 2.5 mmoles/day. Such a
change is similar in magnitude to the mean change in calcium
balance of + 1.6 mmoles/day that accompanied HTZ adminis-
tration. This effect is consistent with recent observations show-
ing the effect of oral NaHCO3 administration to improve
calcium balance when acid production is augmented by increas-
ing dietary protein intake [24].
Fifth, consideration must be given to the possibility that HTZ
either blunted the sensitivity of bone to the resorbing effects of
PTH or 1 ,25-(OH)2-D or in some manner directly reduced bone
resorption. No studies of the effects of HTZ in cultured bone
are apparently available. The thiazide diuretics do have car-
bonic anhydrase inhibitory activity and it has recently been
observed that acetazolamide inhibits 1 ,25-(OH)2-D- stimulated
bone resorption in organ culture [25] and that PTH stimulation
of bone resorption in organ culture is accompanied by increased
carbonic anhydrase activity [26]. Thus, such a mechanism may
mediate the effect of HTZ to inhibit bone resorption.
Finally, the present studies provide further support for the
view that chronic HTZ administration either augments or
preserves bone mass in human beings. The less negative
calcium balance of 1.6 mmoles/day if cumulated over one year
would be approximately 580 mmoles of calcium, or approxi-
mately 2.3% of the 25,000 mmoles of calcium contained in the
skeleton of an adult of average body size. It seems likely that
there is eventual escape from the effect of HTZ to promote Ca
retention. Although chronic HTZ therapy is accompanied by a
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Fig. 5. Serum HCO3 in relation to daily acid balance, (upper panel) Ca
balance in relation to acid balance, (middle panel), and Ca balance in
relation to serum HCO3 (lower panel). Previous studies in subjects
eating normal diets or also given NH4CI [20—23].
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